SI2603217T1 - Novi 6,7-disubstituirani-isokinolinski derivati in njihova uporaba - Google Patents
Novi 6,7-disubstituirani-isokinolinski derivati in njihova uporabaInfo
- Publication number
- SI2603217T1 SI2603217T1 SI201130527T SI201130527T SI2603217T1 SI 2603217 T1 SI2603217 T1 SI 2603217T1 SI 201130527 T SI201130527 T SI 201130527T SI 201130527 T SI201130527 T SI 201130527T SI 2603217 T1 SI2603217 T1 SI 2603217T1
- Authority
- SI
- Slovenia
- Prior art keywords
- disubstituted
- novel
- isoquinoline derivatives
- isoquinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10397511A EP2420237A1 (en) | 2010-08-11 | 2010-08-11 | Fluorinated derivatives of endogenous isoquinolines for use in the treatment of diseases mediated through endogenous isoquinoline pathways |
PCT/FI2011/050707 WO2012020170A1 (en) | 2010-08-11 | 2011-08-10 | Novel 6,7-disubstituted-isoquinoline derivatives and their use |
EP11770473.4A EP2603217B1 (en) | 2010-08-11 | 2011-08-10 | Novel 6,7-disubstituted-isoquinoline derivatives and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2603217T1 true SI2603217T1 (sl) | 2015-08-31 |
Family
ID=43827823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201130527T SI2603217T1 (sl) | 2010-08-11 | 2011-08-10 | Novi 6,7-disubstituirani-isokinolinski derivati in njihova uporaba |
Country Status (16)
Country | Link |
---|---|
US (1) | US8815898B2 (sl) |
EP (2) | EP2420237A1 (sl) |
CN (1) | CN103179971A (sl) |
CA (1) | CA2808016C (sl) |
CY (1) | CY1116588T1 (sl) |
DK (1) | DK2603217T3 (sl) |
ES (1) | ES2541401T3 (sl) |
HR (1) | HRP20150668T1 (sl) |
HU (1) | HUE026482T2 (sl) |
PL (1) | PL2603217T3 (sl) |
PT (1) | PT2603217E (sl) |
RS (1) | RS54081B1 (sl) |
RU (1) | RU2636938C2 (sl) |
SI (1) | SI2603217T1 (sl) |
SM (1) | SMT201500160B (sl) |
WO (1) | WO2012020170A1 (sl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105461626B (zh) * | 2015-12-17 | 2018-05-08 | 浙江工业大学 | 芳环或稠杂环联3,4-二氢异喹啉类共轭结构化合物及其应用 |
CN105585527B (zh) * | 2015-12-17 | 2018-06-26 | 浙江工业大学 | 2-(3,4-二氢异喹啉-1(2h)-亚基)乙腈类化合物及其应用 |
FI130627B (en) | 2021-03-31 | 2023-12-18 | Equinorm Ltd | NEW HETEROCYCLIC COMPOUNDS AND THEIR USE |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2716548B2 (ja) * | 1989-11-01 | 1998-02-18 | 雅昭 廣部 | パーキンソニズム予防・治療剤 |
DE9017900U1 (de) | 1990-12-22 | 1993-01-28 | Boehringer Ingelheim Kg, 55218 Ingelheim | 3,4-Dihydro-1-benzyl-6,7-dimethoxy-α- [di-2-(2,3,4-trimethoxyphenyl)ethyl] aminocarbonyl-isochinolin |
US5491148A (en) | 1991-04-26 | 1996-02-13 | Syntex (U.S.A.) Inc. | Isoquinolinone and dihydroisoquinolinone 5-HT3 receptor antagonists |
US5246943A (en) * | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
WO1998013351A1 (en) | 1996-09-27 | 1998-04-02 | Hoechst Marion Roussel, Inc. | Pictet-spengler reaction for the synthesis of tetrahydroisoquinolines and related heterocyclic compounds |
CN100436420C (zh) * | 1999-11-03 | 2008-11-26 | Amr科技公司 | 4-苯基取代的四氢异喹啉及其用于制备药物的用途 |
WO2006035280A1 (en) | 2004-09-27 | 2006-04-06 | Ranbaxy Laboratories Limited | 3,4-dihydroisoquinoline compounds as muscrinic receptor antagonists for the treatment of respiratory, urinary and gastrointestinal diseases |
US20060111393A1 (en) * | 2004-11-22 | 2006-05-25 | Molino Bruce F | 4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
EP2090576A1 (en) * | 2008-02-01 | 2009-08-19 | Merz Pharma GmbH & Co.KGaA | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators |
-
2010
- 2010-08-11 EP EP10397511A patent/EP2420237A1/en not_active Withdrawn
-
2011
- 2011-08-10 PT PT117704734T patent/PT2603217E/pt unknown
- 2011-08-10 CN CN2011800490170A patent/CN103179971A/zh active Pending
- 2011-08-10 PL PL11770473T patent/PL2603217T3/pl unknown
- 2011-08-10 RS RS20150436A patent/RS54081B1/en unknown
- 2011-08-10 ES ES11770473.4T patent/ES2541401T3/es active Active
- 2011-08-10 US US13/814,987 patent/US8815898B2/en active Active
- 2011-08-10 RU RU2013110377A patent/RU2636938C2/ru not_active Application Discontinuation
- 2011-08-10 EP EP11770473.4A patent/EP2603217B1/en active Active
- 2011-08-10 HU HUE11770473A patent/HUE026482T2/en unknown
- 2011-08-10 DK DK11770473.4T patent/DK2603217T3/en active
- 2011-08-10 CA CA2808016A patent/CA2808016C/en not_active Expired - Fee Related
- 2011-08-10 WO PCT/FI2011/050707 patent/WO2012020170A1/en active Application Filing
- 2011-08-10 SI SI201130527T patent/SI2603217T1/sl unknown
-
2015
- 2015-06-19 HR HRP20150668TT patent/HRP20150668T1/hr unknown
- 2015-07-02 CY CY20151100573T patent/CY1116588T1/el unknown
- 2015-07-03 SM SM201500160T patent/SMT201500160B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RU2013110377A (ru) | 2014-09-20 |
EP2420237A1 (en) | 2012-02-22 |
US20130137719A1 (en) | 2013-05-30 |
CA2808016C (en) | 2018-10-30 |
SMT201500160B (it) | 2015-09-07 |
EP2603217B1 (en) | 2015-04-08 |
RS54081B1 (en) | 2015-10-30 |
CA2808016A1 (en) | 2012-02-16 |
PT2603217E (pt) | 2015-08-26 |
PL2603217T3 (pl) | 2015-09-30 |
CN103179971A (zh) | 2013-06-26 |
HUE026482T2 (en) | 2016-06-28 |
ES2541401T3 (es) | 2015-07-20 |
WO2012020170A1 (en) | 2012-02-16 |
EP2603217A1 (en) | 2013-06-19 |
DK2603217T3 (en) | 2015-07-13 |
US8815898B2 (en) | 2014-08-26 |
RU2636938C2 (ru) | 2017-11-29 |
CY1116588T1 (el) | 2017-03-15 |
HRP20150668T1 (hr) | 2015-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2100032I1 (hu) | Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk | |
IL253870A0 (en) | Certain amino-pyrimidines, their assemblies, and methods of using them | |
HK1199031A1 (en) | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof 2--5--1,2,4- | |
ZA201205788B (en) | 1,2,4-triazine-4-amine derivatives | |
IL222465A0 (en) | Certain amino-pyridazines, compositions thereof, and methods for their use | |
EP2560488A4 (en) | CERTAIN AMINOPYRIMIDINES AND AMINOTRIAZINES, COMPOSITIONS AND METHOD FOR THEIR USE | |
HK1184363A1 (en) | Novel auristatin derivatives and use thereof auristatin | |
ZA201300957B (en) | 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and use thereof | |
SI2598503T1 (sl) | Derivati cis-tetrahidro-spiro(cikloheksan-1,1'-pirido(3,4-b)indol)-4-amina | |
HK1193100A1 (zh) | 苯基- -氮雜-雙環 己- -基-甲酮及其作為藥物的用途 | |
ZA201206630B (en) | Hetaryl-[1,8]naphthyridine derivatives | |
HK1167597A1 (en) | Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics -2e4e- | |
IL223405B (en) | Phosphoplatins, preparations containing them and their uses | |
IL225724A (en) | History of acylbenzene, its salts and their uses | |
IL225440A (en) | Cyclohexane derivatives, preparations containing them and their uses | |
PL2603217T3 (pl) | Nowe pochodne 6,7-dipodstawionej izochinoliny i ich zastosowanie | |
EP2621490A4 (en) | PROPARGYL-TRIFLUOROMETHOXY-AMINO-BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF | |
EP2497768A4 (en) | NEW 2,4-PYRIMIDINE DERIVATIVES AND USES THEREOF | |
GB201000148D0 (en) | Article, its manufacture and use |